A survey commissioned by Canadian cannabis company FIGR Brands Inc and conducted by data service firm Maru/Blue suggests that many Canadians feel uncomfortable discussing their cannabis use with co-workers and family members

The latest quarterly report from the Ontario Cannabis Store (OCS) says that the legal industry has reached a turning point.

Legalization was supposed to open up opportunities for Canadian farmers, but barriers to entry and billions of dollars in foreign investment have cut them out of the big picture.

In 1923, when it became illegal to possess cannabis in Canada, very few Canadians would have heard of the drug, let alone tried it.

So why did legislators target weed?

Cannabis advocates have long blamed women’s rights activist Emily Murphy. Her 1922 book on the drug trade in Canada, The Black Candle, claimed that marijuana users “become raving maniacs” and “are liable to kill or indulge in any sort of violence.”

Canadian medicinal marijuana patients report feeling disadvantaged when it comes to access and pricing, a wrong that could be righted by ensuring that physicians who offer related consultations are covered under provincial plans.

The legal cannabis industry continued to make inroads against its illicit counterparts, as one-quarter of all sales took place among regulated players in the first quarter of the year, according to new data from the Ontario Cannabis Store.

The provincial pot distributor's quarterly review showed that the province controlled a 25.1-per-cent share of the cannabis market in the fiscal first quarter of 2020, a slight uptick from the 24.7 per cent share observed in the previous quarter. The number lagged behind the national share for the legal market, according to OCS and Statistics Canada calculations.  

Despite the fact cannabis has been legal in Canada for some time, many people are still uncomfortable talking about their use of the substance.

A survey conducted by Maru/Blue, commissioned by cannabis-brand FIGR Brands Inc., found that Canadians are uncomfortable discussing their use with their family and colleagues.

According to the results, less than two in five Canadians--39 per cent--were comfortable discussing their cannabis use with their parents, while only 17 per cent were comfortable discussing it with their boss, and 14 per cent were comfortable discussing it with their grandparents.

Few industries offer as much promise this decade as marijuana. After generating $10.9 billion in worldwide sales in 2018, Wall Street analysts are forecasting anywhere from $50 billion to $200 billion in global sales by 2030. While not every pot stock can be a winner, these would appear to be incredible growth figures for investors to piggyback on.

However, there's been a wild divergence to date between the U.S. and Canadian cannabis markets.

A new healthcare technology company, Cannalogue, is launching a petition in their native land of Canada to get the Ministries of Health on board with providing national healthcare coverage for medical cannabis. 

A Canadian health and technology company is circulating a petition pushing for a plan to offer certain patients national coverage for medical cannabis.

Cannalogue, said to be the recipient of Health Canada’s first direct-to-sales licence for medical cannabis, has launched a petition that urges Ottawa to ensure “disadvantaged groups such as seniors, those with disabilities and individuals below the poverty line” have access to drug coverage that extends to medical cannabis.